Literature DB >> 30396562

Changes in serum antimüllerian hormone levels in patients 6 and 12 months after endometrioma stripping surgery.

Vera Miodrag Kovačević1, Luka Momir Anđelić1, Ana Mitrović Jovanović2.   

Abstract

OBJECTIVE: To investigate the impact of laparoscopic endometrioma cystectomy on the ovarian reserve and to identify the most important factors that predict the ovarian reserve in patients with endometriomas.
DESIGN: Prospective study. SETTINGS: Endoscopy unit of a general hospital. PATIENT(S): Fifty-four patients with unilateral (n = 37) and bilateral endometriomas (n = 17). INTERVENTIONS(S): The serum antimüllerian hormone (AMH) concentration was assessed before surgery and at 6 and 12 months after surgery. MAIN OUTCOME MEASURE(S): The primary outcome was the damage to the ovarian reserve, as assessed by the serum AMH concentration. Secondary end points were the persistence or recovery of ovarian damage after 1 year. RESULT(S): AMH concentrations decreased after the laparoscopic excision of cystic ovarian endometriomas. Before surgery and at 6 and 12 months after surgery, the concentrations were, respectively 3.07, 1.29, and 1.46 ng/mL. In the unilateral group, the median AMH levels were 3.31, 1.43, and 1.72 ng/mL, and in the bilateral group the levels were 2.55, 0.98, and 0.89 ng/mL. The serum AMH concentrations thus decreased by 53.27 ± 38.2% and 49.43 ± 38.3% at 6 and 12 months after cystectomy, respectively. CONCLUSION(S): In patients with endometriomas, the decrease in ovarian reserve occurs immediately after the excision of the endometrioma. Significant predictors of AMH values at 6 and 12 months after surgery include the baseline AMH level, patient age, and bilateral endometriomas.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endometrioma; antimüllerian hormone; laparoscopy; ovarian reserve

Mesh:

Substances:

Year:  2018        PMID: 30396562     DOI: 10.1016/j.fertnstert.2018.07.019

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  SOMA-trial: surgery or medication for women with an endometrioma? Study protocol for a randomised controlled trial and cohort study.

Authors:  E van Barneveld; V B Veth; J M Sampat; A M F Schreurs; M van Wely; J E Bosmans; B de Bie; F W Jansen; E R Klinkert; A W Nap; B W J Mol; M Y Bongers; V Mijatovic; J W M Maas
Journal:  Hum Reprod Open       Date:  2020-02-11

2.  Long-Term Follow-Up Of Anti-Mullerian Hormone Levels After Laparoscopic Endometrioma Cystectomy.

Authors:  Nguyen Duy Anh; Nguyen Thi Thu Ha; Nguyen Manh Tri; Do Khac Huynh; Do Tuan Dat; Phan Thi Huyen Thuong; Nguyen Khac Toan; Tran Anh Duc; Nguyen Duc Hinh; Hoang Van Tong
Journal:  Int J Med Sci       Date:  2022-03-21       Impact factor: 3.642

Review 3.  Impact of Surgical Management of Endometrioma on AMH Levels and Pregnancy Rates: A Review of Recent Literature.

Authors:  Ana Sofia Pais; Clara Flagothier; Linda Tebache; Teresa Almeida Santos; Michelle Nisolle
Journal:  J Clin Med       Date:  2021-01-22       Impact factor: 4.241

4.  Correlation of Serum Anti-Mullerian Hormone (AMH) Level on Ovarian Volume in Women with Endometrioma.

Authors:  Dodi Suardi; Wiryawan Permadi; Tono Djuwantono; Yudi Mulyana Hidayat; Hartanto Bayuaji; Gusti Putu Edo Gautama
Journal:  Int J Gen Med       Date:  2021-01-06

Review 5.  The Effect of Laparoscopic Endometrioma Surgery on Anti-Müllerian Hormone: A Systematic Review of the Literature and Meta-Analysis.

Authors:  José Moreno-Sepulveda; Carolina Romeral; Geraldine Niño; Assumpció Pérez-Benavente
Journal:  JBRA Assist Reprod       Date:  2022-01-17

6.  Is ovarian reserve reduction following endometriotic cystectomy predicted? The implication for fertility preservation counseling.

Authors:  Johnny S Younis; Nora Shapso; Ido Izhaki
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-21       Impact factor: 6.055

7.  Impact of perioperative use of GnRH agonist or dienogest on ovarian reserve after cystectomy for endometriomas: a randomized controlled trial.

Authors:  Ayako Muraoka; Satoko Osuka; Atsushi Yabuki; Masato Yoshihara; Hideaki Tanaka; Reina Sonehara; Natsuki Miyake; Mayuko Murakami; Sayako Yoshita; Natsuki Nakanishi; Tomoko Nakamura; Maki Goto; Akira Iwase; Hiroaki Kajiyama
Journal:  Reprod Biol Endocrinol       Date:  2021-12-06       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.